Loperamide Hydrochloride

Product NDC
51079-690
11-digit product format
510790690
Labeler code
51079
Product ID
51079-690_3a865d0e-9176-11dd-e063-6394a90abcba
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
loperamide hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Mylan Institutional Inc.
Application
ANDA072741
Marketing category
ANDA
Marketing start
1997-03-10
Substance
LOPERAMIDE HYDROCHLORIDE
Active strength
2 mg/1
Pharmacologic classes
Opioid Agonist [EPC], Opioid Agonists [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Loperamide Hydrochloride
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LOPERAMIDE HYDROCHLORIDE2 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii77TI35393C
Rxcui978006

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
10f838ef-a72b-645d-80f8-e2255205c3b1Product name620240805

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51079-690-01Loperamide Hydrochloride1 in 1 BLISTER PACKCAPSULE117
51079-690-20Loperamide Hydrochloride100 in 1 CARTONCAPSULE10017

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-690-01EA - Each51079-6904578ccd6-d06f-474b-adb8-22f5baa4321d12012-07-24
51079-690-17EA - Each51079-690815e38c8-32ac-446a-a9e7-37f0ac0d710212012-07-24
51079-690-19EA - Each51079-69062dbf0fa-2fc8-4e04-9a04-40676dad5ad912012-07-24
51079-690-20EA - Each51079-690133b8399-d29b-47f1-868c-82408366cad112012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LOPERAMIDE HYDROCHLORIDEACTIVE INGREDIENT77TI35393CLOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
LOPERAMIDEACTIVE MOIETY6X9OC3H4IILOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
GELATININACTIVE INGREDIENT2G86QN327LLOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XLOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]4
LOPERAMIDE HYDROCHLORIDEACTIVE INGREDIENT77TI35393CLOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
LOPERAMIDEACTIVE MOIETY6X9OC3H4IILOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
GELATININACTIVE INGREDIENT2G86QN327LLOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XLOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2LOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLOPERAMIDE HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51079-690LOPERAMIDE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]16Current NDC, Legacy NDC, 2 package rows20240530_ad71d4ab-d293-47a2-8f3f-2c9f42d76e40.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
978006loperamide HCl 2 MG Oral CapsulePSNad71d4ab-d293-47a2-8f3f-2c9f42d76e4017
978006loperamide hydrochloride 2 MG Oral CapsuleSCDad71d4ab-d293-47a2-8f3f-2c9f42d76e4017
978006loperamide HCl 2 MG Oral CapsulePSNbe99224e-dd49-4628-a5bf-ed8469ffd4a412
978006loperamide hydrochloride 2 MG Oral CapsuleSCDbe99224e-dd49-4628-a5bf-ed8469ffd4a412

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51079-690-01510790690011 in 1 BLISTER PACKHistorical
51079-690-2051079069020100 BLISTER PACK in 1 CARTON (51079-690-20) / 1 CAPSULE in 1 BLISTER PACK (51079-690-01) 100 blister pack1997-03-100000-00-00NoNoCurrent